Psoriasis, psoriatic arthritis and increased risk of incident Crohn's disease in US women

Smoking and Risk of Incident Psoriasis Among Women and Men in the United States: A Combined Analysis

(2012) Wenqing Li et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

Obesity and risk of incident psoriatic arthritis in US women

(2012) Wenqing Li et al.   ANNALS OF THE RHEUMATIC DISEASES

Smoking and risk of incident psoriatic arthritis in US women

(2011) Wenqing Li et al.   ANNALS OF THE RHEUMATIC DISEASES

The association between smoking and the development of psoriatic arthritis among psoriasis patients

(2011) Lihi Eder et al.   ANNALS OF THE RHEUMATIC DISEASES

Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)

(2011) J. Barker et al.   BRITISH JOURNAL OF DERMATOLOGY

TH1 and TH17 interactions in untreated inflamed mucosa of inflammatory bowel disease, and their potential to mediate the inflammation

(2011) Trine Olsen et al.   CYTOKINE

Is Obesity a Risk Factor for Crohn’s Disease?

(2011) Michael A. Mendall et al.   DIGESTIVE DISEASES AND SCIENCES

Epidemiology and Natural History of Inflammatory Bowel Diseases

(2011) Jacques Cosnes et al.   GASTROENTEROLOGY

Epidemiology and comorbidities of psoriasis patients in a national database in Taiwan

(2011) Tsen-Fang Tsai et al.   JOURNAL OF DERMATOLOGICAL SCIENCE

The effects of adalimumab treatment and psoriasis severity on self-reported work productivity and activity impairment for patients with moderate to severe psoriasis

(2011) Alexa Boer Kimball et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY

Associated comorbidities in psoriasis and inflammatory bowel disease

(2011) A.M. Binus et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Adalimumab for the treatment of inflammatory bowel disease

(2011) Sharmeel K Wasan et al.   Expert Review of Gastroenterology & Hepatology

Frequency and Risk Factors for Extraintestinal Manifestations in the Swiss Inflammatory Bowel Disease Cohort

(2010) Stephan R Vavricka et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Infliximab and adalimumab-induced psoriasis in Crohn's disease: A paradoxical side effect

(2010) Marisa Iborra et al.   Journal of Crohns & Colitis

Validity, reliability, and sensitivity-to-change properties of the psoriatic arthritis screening and evaluation questionnaire

(2009) Patrick Lee Dominguez et al.   ARCHIVES OF DERMATOLOGICAL RESEARCH

Development and pilot-testing of a psoriasis screening tool

(2009) P.L. Dominguez et al.   BRITISH JOURNAL OF DERMATOLOGY

Differential regulation of interleukin 17 and interferon   production in inflammatory bowel disease

(2009) L. Rovedatti et al.   GUT

Psoriasis associated with ulcerative colitis and Crohn's disease

(2009) AD Cohen et al.   JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY

Psoriasis genome-wide association study identifies susceptibility variants within LCE gene cluster at 1q21

(2009) Xue-Jun Zhang et al.   NATURE GENETICS

Inflammatory Bowel Disease

(2009) Clara Abraham et al.   NEW ENGLAND JOURNAL OF MEDICINE

New insights into the pathogenesis and genetics of psoriatic arthritis

(2009) Kristine E Nograles et al.   Nature clinical practice. Rheumatology

IL23 differentially regulates the Th1/Th17 balance in ulcerative colitis and Crohn's disease

(2008) T Kobayashi et al.   GUT

IFN-Regulatory Factor 5 Gene Variants Interact with the Class I MHC Locus in the Swedish Psoriasis Population

(2008) Fabio O. Sánchez et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

T-Helper 17 Cells in Psoriatic Plaques and Additional Genetic Links between IL-23 and Psoriasis

(2008) Andrew Blauvelt   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Psoriasis Vulgaris Lesions Contain Discrete Populations of Th1 and Th17 T Cells

(2008) Michelle A. Lowes et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

The prevalence of previously diagnosed and undiagnosed psoriasis in US adults: Results from NHANES 2003-2004

(2008) Shanu Kohli Kurd et al.   JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY